Fidelity Investments’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.42M | Buy |
234,150
+7,837
| +3% | +$75.6K | ﹤0.01% | 2573 |
|
|
2026
Q1 | $1.68M | Buy |
226,313
+55,826
| +33% | +$587K | ﹤0.01% | 2694 |
|
|
2025
Q4 | $2M | Buy |
170,487
+133,359
| +359% | +$1.44M | ﹤0.01% | 2619 |
|
|
2025
Q3 | $287K | Sell |
37,128
-117,243
| -76% | -$821K | ﹤0.01% | 3229 |
|
|
2025
Q2 | $1.13M | Buy |
154,371
+146,106
| +1,768% | +$1.18M | ﹤0.01% | 2678 |
|
|
2025
Q1 | $78.4K | Sell |
8,265
-17,548
| -68% | -$219K | ﹤0.01% | 3664 |
|
|
2024
Q4 | $425K | Buy |
25,813
+12,558
| +95% | +$195K | ﹤0.01% | 2991 |
|
|
2024
Q3 | $196K | Buy |
13,255
+931
| +8% | +$14.6K | ﹤0.01% | 3207 |
|
|
2024
Q2 | $171K | Sell |
12,324
-2,892
| -19% | -$41K | ﹤0.01% | 3083 |
|
|
2024
Q1 | $239K | Buy |
15,216
+663
| +5% | +$10.2K | ﹤0.01% | 2975 |
|
|
2023
Q4 | $235K | Buy |
14,553
+6,441
| +79% | +$105K | ﹤0.01% | 2913 |
|
|
2023
Q3 | $99.8K | Sell |
8,112
-459
| -5% | -$6.83K | ﹤0.01% | 3094 |
|
|
2023
Q2 | $138K | Sell |
8,571
-728
| -8% | -$12K | ﹤0.01% | 3056 |
|
|
2023
Q1 | $162K | Buy |
9,299
+1,403
| +18% | +$20K | ﹤0.01% | 3055 |
|
|
2022
Q4 | $73K | Sell |
7,896
-6,345
| -45% | -$59.1K | ﹤0.01% | 3319 |
|
|
2022
Q3 | $122K | Buy |
14,241
+3,520
| +33% | +$35K | ﹤0.01% | 3202 |
|
|
2022
Q2 | $88K | Buy |
10,721
+8,497
| +382% | +$81.1K | ﹤0.01% | 3376 |
|
|
2022
Q1 | $27K | Buy |
2,224
+337
| +18% | +$7.09K | ﹤0.01% | 3900 |
|
|
2021
Q4 | $65K | Sell |
1,887
-178
| -9% | -$6.97K | ﹤0.01% | 3174 |
|
|
2021
Q3 | $99K | Buy |
2,065
+973
| +89% | +$45K | ﹤0.01% | 3079 |
|
|
2021
Q2 | $49K | Buy |
1,092
+42
| +4% | +$1.86K | ﹤0.01% | 3168 |
|
|
2021
Q1 | $51K | Sell |
1,050
-362
| -26% | -$18.8K | ﹤0.01% | 3041 |
|
|
2020
Q4 | $76K | Sell |
1,412
-931
| -40% | -$42.1K | ﹤0.01% | 2930 |
|
|
2020
Q3 | $86K | Buy |
2,343
+1,114
| +91% | +$41.4K | ﹤0.01% | 2815 |
|
|
2020
Q2 | $38K | Buy |
1,229
+262
| +27% | +$7.26K | ﹤0.01% | 2851 |
|
|
2020
Q1 | $27K | Sell |
967
-37
| -4% | -$1.11K | ﹤0.01% | 2891 |
|
|
2019
Q4 | $30K | Sell |
1,004
-124,182
| -99% | -$2.96M | ﹤0.01% | 3016 |
|
|
2019
Q3 | $2.39M | Buy |
125,186
+123,837
| +9,180% | +$2.9M | ﹤0.01% | 2228 |
|
|
2019
Q2 | $29K | Buy |
1,349
+1,302
| +2,770% | +$28.6K | ﹤0.01% | 2988 |
|
|
2019
Q1 | $1K | Buy |
+47
| New | +$817 | ﹤0.01% | 3495 |
|
Other funds holding NEO
FLAM
GF
NAMI
B
Fidelity Investments's NEO Position: Q2 2026 in Review
Fidelity Investments increased its NeoGenomics (NEO) stake by 3.5% in Q2 2026, buying an estimated $75.6K and bringing the position to 234,150 shares worth $3.42M. The position accounts for ﹤0.01% of the portfolio, ranked #2573.
Fidelity Investments first reported a position in NEO in Q1 2019 and has held it in 30 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Fidelity Investments held 234,150 shares of NeoGenomics worth $3.42M as of Q2 2026.
- Fidelity Investments bought 7,837 NeoGenomics shares in Q2 2026, an estimated $75.6K.
- NeoGenomics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #2573 holding.
- Fidelity Investments first reported a position in NeoGenomics in Q1 2019 and has held it in 30 quarters since.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.